Skip to main content

Table 1 Mean arterial blood pressure (mABP; mmHg), plasma glucose (mg/dl), and glycosylated hemoglobin (HbA1c, %)

From: Curcumin supplementation could improve diabetes-induced endothelial dysfunction associated with decreased vascular superoxide production and PKC inhibition

Group mABP (mmHg) Plasma glucose (mg/dL) HbA1c (%)
control 103.1 ± 3.57 101.8 ± 4.89 3.68 ± 0.17
con+cur300 106.18 ± 3.93NS 106.8 ± 0.92NS 4.08 ± 0.41NS
DM 151.67 ± 9.68** 459.0 ± 24.40** 10.73 ± 0.32**
DM+cur30 128.33 ± 3.57 360.8 ± 35.82** 8.20 ± 0.88**, †
DM+cur300 122.27 ± 8.68† 310.00 ± 32.73**, † 7.90 ± 0.97**, †
  1. Values are means ± SEM (n = 10) from the groups of: 12-week STZ (DM), diabetes treated with curcumin (DM+cur30, DM+cur300), controls (con) and controls treated with curcumin (con+cur300). NS, no significant difference compared to control, **P < 0.01, significant difference compared to control and control treated with curcumin; † P < 0.05, significant difference from diabetic rats.
\